MYD88 and Hepatic fibrosis: The TLR4–MyD88–NF-κB axis is a well-established driver of hepatic fibrosis, promoting hepatocyte injury, HSC activation, and pro-inflammatory cytokine release (Rodríguez et al., 2021; Wu et al., 2024).